Forte Biosciences, Inc. · NASDAQ:FBRX
Alger Associates, Inc. 13-3017981 reported a 17.70% stake in Forte Biosciences, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Alger Associates, Inc. 13-3017981 reported a 17.70% stake in Forte Biosciences, Inc., 1,133,944 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 17.70%
- Shares
- 1,133,944
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Alger Associates, Inc. 13-3017981 | 17.70% | 1,133,944 |
Source
Related
- Forte Biosciences, Inc.
- Alger Associates, Inc.
- Forte Biosciences, Inc. shareholders
- Schedule 13G/A · Alger Associates, Inc. · Aug 7, 2026
- Schedule 13G/A · Alger Associates, Inc. · May 15, 2026
- Schedule 13G/A · Alger Associates, Inc. · Nov 14, 2025
- Schedule 13G/A · Alger Associates, Inc. · Aug 14, 2025
- Schedule 13G/A · Alger Associates, Inc. · May 15, 2025
- Schedule 13G/A · Federated Hermes, Inc. · Sep 8, 2026
- Form 4 · Kornfeld Steven · Aug 27, 2026
- Form 4 · Gryska David W · Aug 27, 2026
- Form 4 · Riley Antony A · Aug 27, 2026
- Form 4 · Wagner Paul A. · Aug 27, 2026